Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1/Phase 2

Vasopressin and Pain Perception in the Brain

University of Maryland, Baltimore · NCT03446456

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1, Phase 2
Target enrollment
56
US sites recruiting
1
Study start
September 17, 2018
Record last updated
July 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The feeling of pain is not just a sensory experience, but is also influenced by emotions, beliefs and expectations, making pain a highly subjective experience. This is evident in clinical practice, where the behavior of the physician and the treatment context can strongly influence the pain experience of patients. Research has shown that patients' expectation that a treatment will reduce pain influences individual perception of pain, even if the treatment has no active ingredient. The expectancy-induced analgesia emerges due to a modulation of the individual pain experience of patients by an engagement of endogenous inhibitory systems in the central nervous system.

The development of expectancy-induced analgesia can be generated in several ways. The investigators have previously demonstrated that social information and observational learning (e.g. the patient observes analgesia in another person receiving a treatment) can lead to expectancy-induced analgesia and pain reduction. However, the neural mechanisms (mechanisms in the brain) of how these expectancies are acquired and the neural mechanisms of analgesia induced by observational learning are unknown.

The investigators recently established a procedure to investigate neural mechanisms of observational learning in placebo analgesia. Here the investigators propose to investigate the influence of vasopressin, a neurotransmitter that is important for social interaction, on observational learning.

The investigators will use functional magnetic resonance imaging (fMRI), a non-invasive method, to investigate neural activity in humans. Participants will either receive vasopressin or saline with a nasal spray. During fMRI scanning, participants will then undergo an observational learning phase, where the study participants will learn the experience of analgesia in another person through a video, and a testing phase, where participants will perceive painful stimulations with the same cues as the observational phase. The comparison of the vasopressin group and the saline group will allow us to investigate how vasopressin influences behavioral effects of observational learning on pain perception as well as its effect on the neural processing of observational learning.

A better understanding of how the human brain processes observationally-induced analgesia would allow us to improve the therapeutic context of pain treatments by increasing the contextual factors which help patients cope with pain.

Being studied: Arginine vasopressin; Saline; Observational learning; fMRI data aquisition

Conditions: Acute Pain

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Age ( 18-55 years old)
  • English speaker (written and spoken)

Exclusion Criteria

  • Cardiovascular, neurological diseases, pulmonary abnormalities, kidney disease, liver disease, degenerative neuromuscular disease, history of cancer within past 3 years
  • Any history of chronic pain disorder or currently in pain
  • Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, mania, autism) and /or psychiatric condition leading to treatment and/or hospitalization within the last 3 years.
  • Family (first degree) history of mania, schizophrenia, or other psychoses
  • Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
  • Pregnancy or breast feeding
  • Color-blindness
  • Impaired, uncorrected hearing
  • History of angioedema
  • High blood pressure (above 140 mmHg) or symptomatic low blood pressure
  • History of fainting
  • Left handed
  • Allergies or sensitivities to creams, lotions or food coloring
  • Any non-organic implant or any non-removable metal device (e.g. pacemaker, cochlear implants, stents, surgical clips, non-removable piercings)
  • Any prior eye injury or the potential of a foreign body in the eye (e.g. worked in metal fields)Persisting functional impairment due to a head trauma
  • Fear of closed spaces
  • Any other contraindications for MRI (e.g. large tattoos on head and neck)
  • Previously participated in a "Pain Perception in the Brain" Study
  • Failed drug test (testing for opiates, cocaine, methamphetamines, amphetamines and THC)

Recruiting US locations

  • Luana Colloca

    Baltimore, MD 21201-1512

    Site contact: Luana Colloca, MD, PhD, MS · 301-364-8089 · colloca@umaryland.edu

Study contacts (from the official record)

  • Research Coordinator · 410-706-5975 · nrscollocalab@umaryland.edu
  • Rachel Massalee, MS · rmassalee@umaryland.edu
All diabetes studies in Maryland →
Vasopressin and Pain Perception in the Brain (NCT03446456) | Bored Studies